EUVIMEDEUVIMED entdecken
Open Access

Impact of Synchronous B3 Lesions on Clinicopathological Data and Prognosis in Patients with Breast Cancer

Eray Balci, Ersin Turan, Hande Koksal

Breast Care · 11.05.2026 · 1-10

DOI: 10.1159/000552454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Care, online erschienen am 11.05.2026. Verfasst von Eray Balci und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Bursa Faculty of Medicine, University of Health Sciences, Bursa City Hospital, Bursa, Turkey. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Breast cancer is a significant disease as it is the most frequently diagnosed cancer and the leading cause of cancer-related mortality among women. The factors affecting the prognosis of breast cancer are receiving considerable attention. Although lesions with uncertain malignant potential (B3 lesions) show benign histological characteristics, they are associated with an increased risk of malignancy.

Methods

This study included 296 patients who underwent surgery and were followed up with a diagnosis of breast cancer in our clinic. The patients were divided into two groups based on the presence of at least one pathologically confirmed B3 lesion in the surgical specimen. The demographic characteristics and clinicopathological data of the patients were recorded, and the effect of B3 lesions on prognosis was examined. Recurrence and metastasis dates were examined to evaluate disease-free survival and overall prognosis.

Results

It was observed that patients with breast cancer who had accompanying B3 lesions were diagnosed at an earlier stage and had better survival rates than those without these lesions. The survival and disease-free survival rates of patients with lobular neoplasia accompanying invasive lobular carcinoma were better compared to those without this condition.

Conclusion

In this study, breast cancer patients with concomitant B3 lesions were diagnosed at earlier stages, and the presence of B3 lesions in early-stage disease was associated with improved prognosis. This may be explained by earlier clinical presentation due to symptoms related to B3 lesions or by more frequent imaging surveillance prompted by their detection. Another possible explanation is that cancers associated with B3 lesions may exhibit more favorable tumor biology and prognostic features.

Schlagwörter

Stichwörter der Autor:innen

B3 lesionsBreast cancerPrognosis

Autor:innen und Institutionen

  • Department of Surgical Oncology, Bursa Faculty of Medicine, University of Health Sciences, Bursa City Hospital, Bursa, Turkey.
  • Department of General Surgery, Hamidiye Faculty of Medicine, Konya City Hospital, Health Sciences University, Konya, Turkey.
  • Department of General Surgery, Faculty of Medicine, Selcuk University, Konya, Turkey.

Zitieren

APA

Balci, E., Turan, E., & Koksal, H. (2026). Impact of Synchronous B3 Lesions on Clinicopathological Data and Prognosis in Patients with Breast Cancer. Breast Care, 1-10. https://doi.org/10.1159/000552454

Vancouver

Balci E, Turan E, Koksal H. Impact of Synchronous B3 Lesions on Clinicopathological Data and Prognosis in Patients with Breast Cancer. Breast Care. 2026:1-10. doi:10.1159/000552454

BibTeX
@article{Balci2026,
  author = {Balci, Eray and Turan, Ersin and Koksal, Hande},
  title = {Impact of Synchronous B3 Lesions on Clinicopathological Data and Prognosis in Patients with Breast Cancer},
  journal = {Breast Care},
  year = {2026},
  pages = {1--10},
  doi = {10.1159/000552454}
}
Kostenlos starten →